PDB Short entry for 2WS6 HEADER HORMONE 03-SEP-09 2WS6 TITLE SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN HEXAMER TITLE 2 FORM CAVEAT 2WS6 THR D 27 C-ALPHA IS PLANAR COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN A CHAIN; COMPND 3 CHAIN: A, C, E, G, I, K; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: A CHAIN OF HUMAN INSULIN; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: INSULIN B CHAIN; COMPND 8 CHAIN: B, D; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 3; COMPND 11 MOLECULE: INSULIN B CHAIN; COMPND 12 CHAIN: F, H, J, L; COMPND 13 ENGINEERED: YES; COMPND 14 OTHER_DETAILS: METHYLATION OF TYROSINE RESIDUE 26 NITROGEN ATOM OF COMPND 15 HUMAN INSULIN SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 MOL_ID: 3; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606 KEYWDS CARBOHYDRATE METABOLISM, GLUCOSE METABOLISM, HORMONE, ANALOGUE, KEYWDS 2 DIABETES MELLITUS EXPDTA X-RAY DIFFRACTION AUTHOR A.M.BRZOZOWSKI,J.JIRACEK,L.ZAKOVA,E.ANTOLIKOVA,C.J.WATSON, AUTHOR 2 J.P.TURKENBURG,G.G.DODSON REVDAT 3 20-DEC-23 2WS6 1 REMARK LINK REVDAT 2 04-APR-12 2WS6 1 CAVEAT JRNL REMARK VERSN REVDAT 1 09-FEB-10 2WS6 0 JRNL AUTH J.JIRACEK,L.ZAKOVA,E.ANTOLIKOVA,C.J.WATSON,J.P.TURKENBURG, JRNL AUTH 2 G.G.DODSON,A.M.BRZOZOWSKI JRNL TITL IMPLICATIONS FOR THE ACTIVE FORM OF HUMAN INSULIN BASED ON JRNL TITL 2 THE STRUCTURAL CONVERGENCE OF HIGHLY ACTIVE HORMONE JRNL TITL 3 ANALOGUES. JRNL REF PROC.NATL.ACAD.SCI.USA V. 107 1966 2010 JRNL REFN ISSN 0027-8424 JRNL PMID 20133841 JRNL DOI 10.1073/PNAS.0911785107 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0082 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 47779 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.152 REMARK 3 R VALUE (WORKING SET) : 0.150 REMARK 3 FREE R VALUE : 0.200 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2565 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3437 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.32 REMARK 3 BIN R VALUE (WORKING SET) : 0.2140 REMARK 3 BIN FREE R VALUE SET COUNT : 201 REMARK 3 BIN FREE R VALUE : 0.2720 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2306 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 244 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.66000 REMARK 3 B22 (A**2) : -0.53000 REMARK 3 B33 (A**2) : -0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.17000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.079 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.073 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.043 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.533 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.970 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.953 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2561 ; 0.025 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3488 ; 2.173 ; 1.955 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 317 ; 7.259 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 128 ;33.961 ;24.531 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 391 ;13.913 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;19.509 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 371 ; 0.204 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2020 ; 0.012 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1544 ; 2.475 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2485 ; 3.697 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1017 ; 4.873 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1003 ; 6.691 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 2561 ; 3.049 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 249 ;12.161 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 2486 ; 6.655 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 21 REMARK 3 RESIDUE RANGE : B 1 B 26 REMARK 3 ORIGIN FOR THE GROUP (A): 24.7161 -0.5696 11.4187 REMARK 3 T TENSOR REMARK 3 T11: 0.0230 T22: 0.0393 REMARK 3 T33: 0.0812 T12: 0.0085 REMARK 3 T13: -0.0222 T23: -0.0154 REMARK 3 L TENSOR REMARK 3 L11: 2.2601 L22: 0.9056 REMARK 3 L33: 2.1288 L12: -0.3890 REMARK 3 L13: -1.1200 L23: 0.5111 REMARK 3 S TENSOR REMARK 3 S11: -0.0403 S12: -0.2694 S13: 0.2173 REMARK 3 S21: 0.0486 S22: 0.0247 S23: -0.1617 REMARK 3 S31: 0.0154 S32: 0.1819 S33: 0.0155 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 1 C 21 REMARK 3 RESIDUE RANGE : D 1 D 26 REMARK 3 ORIGIN FOR THE GROUP (A): 21.0421 13.3057 2.5936 REMARK 3 T TENSOR REMARK 3 T11: 0.0288 T22: 0.0173 REMARK 3 T33: 0.0214 T12: -0.0022 REMARK 3 T13: -0.0077 T23: -0.0170 REMARK 3 L TENSOR REMARK 3 L11: 2.0419 L22: 1.8005 REMARK 3 L33: 0.3314 L12: 1.1817 REMARK 3 L13: 0.3299 L23: -0.1680 REMARK 3 S TENSOR REMARK 3 S11: -0.0151 S12: -0.0714 S13: 0.0581 REMARK 3 S21: 0.0823 S22: 0.0149 S23: -0.0420 REMARK 3 S31: -0.0560 S32: 0.0110 S33: 0.0002 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E 1 E 21 REMARK 3 RESIDUE RANGE : F 1 F 29 REMARK 3 ORIGIN FOR THE GROUP (A): 8.3512 -12.8580 2.4047 REMARK 3 T TENSOR REMARK 3 T11: 0.0312 T22: 0.0171 REMARK 3 T33: 0.0111 T12: -0.0118 REMARK 3 T13: 0.0050 T23: 0.0063 REMARK 3 L TENSOR REMARK 3 L11: 1.2204 L22: 1.2494 REMARK 3 L33: 0.7338 L12: 0.8149 REMARK 3 L13: -0.2151 L23: 0.2416 REMARK 3 S TENSOR REMARK 3 S11: -0.0485 S12: -0.0255 S13: -0.0910 REMARK 3 S21: -0.0090 S22: 0.0050 S23: -0.0310 REMARK 3 S31: 0.0675 S32: -0.0371 S33: 0.0434 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : G 1 G 21 REMARK 3 RESIDUE RANGE : H 1 H 27 REMARK 3 ORIGIN FOR THE GROUP (A): 4.5798 -0.3822 12.1986 REMARK 3 T TENSOR REMARK 3 T11: 0.0198 T22: 0.0109 REMARK 3 T33: 0.0116 T12: 0.0033 REMARK 3 T13: 0.0095 T23: -0.0049 REMARK 3 L TENSOR REMARK 3 L11: 0.3390 L22: 0.3101 REMARK 3 L33: 2.0935 L12: -0.0072 REMARK 3 L13: 0.4574 L23: -0.4180 REMARK 3 S TENSOR REMARK 3 S11: -0.0224 S12: -0.0328 S13: -0.0053 REMARK 3 S21: 0.0598 S22: -0.0092 S23: 0.0328 REMARK 3 S31: -0.0835 S32: -0.0660 S33: 0.0316 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : I 1 I 21 REMARK 3 RESIDUE RANGE : J 1 J 28 REMARK 3 ORIGIN FOR THE GROUP (A): 22.3943 -0.4647 -10.9004 REMARK 3 T TENSOR REMARK 3 T11: 0.0187 T22: 0.0064 REMARK 3 T33: 0.0048 T12: 0.0022 REMARK 3 T13: 0.0003 T23: -0.0008 REMARK 3 L TENSOR REMARK 3 L11: 0.7676 L22: 0.6362 REMARK 3 L33: 0.9718 L12: -0.0627 REMARK 3 L13: 0.0287 L23: -0.3242 REMARK 3 S TENSOR REMARK 3 S11: -0.0258 S12: 0.0431 S13: -0.0038 REMARK 3 S21: 0.0026 S22: -0.0162 S23: -0.0411 REMARK 3 S31: -0.0080 S32: 0.0266 S33: 0.0420 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : K 1 K 21 REMARK 3 RESIDUE RANGE : L 1 L 27 REMARK 3 ORIGIN FOR THE GROUP (A): 6.3645 1.7121 -10.7011 REMARK 3 T TENSOR REMARK 3 T11: 0.0260 T22: 0.0195 REMARK 3 T33: 0.0029 T12: 0.0090 REMARK 3 T13: -0.0060 T23: -0.0032 REMARK 3 L TENSOR REMARK 3 L11: 1.1572 L22: 1.1822 REMARK 3 L33: 1.2347 L12: -0.6372 REMARK 3 L13: -0.8075 L23: 0.8786 REMARK 3 S TENSOR REMARK 3 S11: 0.0344 S12: 0.1269 S13: -0.0279 REMARK 3 S21: -0.0895 S22: -0.0811 S23: 0.0185 REMARK 3 S31: -0.0894 S32: -0.0962 S33: 0.0467 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES RESIDUAL ONLY. A14, B21, C4, D1, I4, I14, L1 REMARK 3 SIDE CHAINS OCCUPANCIES ARE SET TO ZERO DUE TO HIGH MOBILITY OF REMARK 3 THESE SIDE CHAINS. B27-B30, D28-D30 F30, H28-H30, L28-L30 ARE REMARK 3 NOT MODELLED DUE TO DISORDER. REMARK 4 REMARK 4 2WS6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-SEP-09. REMARK 100 THE DEPOSITION ID IS D_1290041025. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JAN-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9340 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50473 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.48000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1MSO REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 6% TRIS PH 8.2, 0.1 M NA CITRATE, REMARK 280 0.02% ZN ACETATE, 0.06% PHENOL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.96350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DODECAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DODECAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 18740 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -234.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G, H, I, J, REMARK 350 AND CHAINS: K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10850 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -103.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, G, H, K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -104.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F, I, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.3 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: I, J, K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR B 27 REMARK 465 PRO B 28 REMARK 465 LYS B 29 REMARK 465 THR B 30 REMARK 465 PRO D 28 REMARK 465 LYS D 29 REMARK 465 THR D 30 REMARK 465 THR F 30 REMARK 465 PRO H 28 REMARK 465 LYS H 29 REMARK 465 THR H 30 REMARK 465 LYS J 29 REMARK 465 THR J 30 REMARK 465 PRO L 28 REMARK 465 LYS L 29 REMARK 465 THR L 30 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 TYR A 14 CD1 CD2 CE1 CE2 CZ OH REMARK 480 GLU B 21 CG CD OE1 OE2 REMARK 480 GLU C 4 CG CD OE1 OE2 REMARK 480 PHE D 1 CG CD1 CD2 CE1 CE2 CZ REMARK 480 LYS F 29 CB CG CD CE NZ REMARK 480 GLU H 21 CD OE1 OE2 REMARK 480 GLU I 4 CD OE1 OE2 REMARK 480 TYR I 14 CG CD1 CD2 CE1 CE2 CZ OH REMARK 480 TYR K 14 CE1 CE2 CZ OH REMARK 480 PHE L 1 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH L 2017 O HOH L 2018 1.86 REMARK 500 OE1 GLU B 13 OG SER D 9 1.96 REMARK 500 CD2 LEU H 17 O HOH H 2008 1.99 REMARK 500 CG GLU H 13 O HOH F 2008 2.00 REMARK 500 O GLN E 5 O HOH E 2001 2.06 REMARK 500 C TYR B 26 O HOH B 2025 2.07 REMARK 500 O HOH J 2005 O HOH L 2004 2.15 REMARK 500 OXT ASN C 21 O HOH C 2024 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CB PHE J 1 O HOH C 2023 2645 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 21 CB GLU B 21 CG -0.148 REMARK 500 GLU C 4 CB GLU C 4 CG -0.148 REMARK 500 GLU C 17 CB GLU C 17 CG -0.134 REMARK 500 GLU D 13 CD GLU D 13 OE2 0.081 REMARK 500 CYS E 7 CB CYS E 7 SG -0.123 REMARK 500 TYR G 19 CE2 TYR G 19 CD2 -0.095 REMARK 500 GLU I 4 CG GLU I 4 CD -0.097 REMARK 500 PHE L 1 CB PHE L 1 CG -0.160 REMARK 500 GLU L 13 CB GLU L 13 CG -0.256 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU I 13 CB - CG - CD1 ANGL. DEV. = -12.4 DEGREES REMARK 500 PHE L 1 CA - CB - CG ANGL. DEV. = 14.6 DEGREES REMARK 500 PHE L 1 CB - CG - CD2 ANGL. DEV. = 7.5 DEGREES REMARK 500 PHE L 1 CB - CG - CD1 ANGL. DEV. = -7.4 DEGREES REMARK 500 GLU L 13 CB - CG - CD ANGL. DEV. = -17.0 DEGREES REMARK 500 GLU L 13 CG - CD - OE1 ANGL. DEV. = -13.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 YNM J 26 95.58 -161.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 CYS A 20 ASN A 21 57.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C2003 DISTANCE = 6.86 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 ZINC (ZN): ZINC CATION REMARK 600 CHLORINE (CL): CHLORINE ANION REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN J1030 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 10 NE2 REMARK 620 2 HIS F 10 NE2 105.8 REMARK 620 3 HIS J 10 NE2 109.8 104.3 REMARK 620 4 CL J1029 CL 112.1 113.9 110.5 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN L1029 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 10 NE2 REMARK 620 2 HIS H 10 NE2 106.6 REMARK 620 3 HIS L 10 NE2 107.5 105.7 REMARK 620 4 CL L1028 CL 111.2 110.7 114.6 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH A 1022 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH C 1022 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH E 1022 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH G 1022 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH I 1022 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL J 1029 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN J 1030 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPH K 1022 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL L 1028 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN L 1029 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL L 1030 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HIT RELATED DB: PDB REMARK 900 INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY GLY (F24G) (NMR, REMARK 900 REPRESENTATIVE PLUS 8 STRUCTURES) REMARK 900 RELATED ID: 2HHO RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-SER, HIS-B10-ASP PRO- REMARK 900 B28-LYS, LYS- B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 2C8Q RELATED DB: PDB REMARK 900 INSULINE(1SEC) AND UV LASER EXCITED FLUORESCENCE REMARK 900 RELATED ID: 1TYL RELATED DB: PDB REMARK 900 INSULIN (T3R3) (PH 6.4, 0.75 M NACL) COMPLEXED WITH TWO ZINC IONS REMARK 900 AND TYLENOL ( 4'-HYDROXYACETANILIDE) REMARK 900 RELATED ID: 2C8R RELATED DB: PDB REMARK 900 INSULINE(60SEC) AND UV LASER EXCITED FLUORESCENCE REMARK 900 RELATED ID: 1T1K RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ALA, REMARK 900 PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1XDA RELATED DB: PDB REMARK 900 STRUCTURE OF INSULIN REMARK 900 RELATED ID: 1HTV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN REMARK 900 RELATED ID: 1MSO RELATED DB: PDB REMARK 900 T6 HUMAN INSULIN AT 1.0 A RESOLUTION REMARK 900 RELATED ID: 1UZ9 RELATED DB: PDB REMARK 900 CRYSTALLOGRAPHIC AND SOLUTION STUDIES OF N- LITHOCHOLYL INSULIN: A REMARK 900 NEW GENERATION OF PROLONGED-ACTING INSULINS. REMARK 900 RELATED ID: 1FUB RELATED DB: PDB REMARK 900 FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION REMARK 900 DATA REMARK 900 RELATED ID: 1TYM RELATED DB: PDB REMARK 900 INSULIN (T3R3) (PH 5.6, 1.0 M NACL) COMPLEXED WITH TWO ZINC IONS REMARK 900 AND TYLENOL ( 4'-HYDROXYACETANILIDE) REMARK 900 RELATED ID: 1HUI RELATED DB: PDB REMARK 900 INSULIN MUTANT (B1, B10, B16, B27)GLU, DES -B30, NMR, 25 STRUCTURES REMARK 900 RELATED ID: 2VK0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS REMARK 900 RELATED ID: 1VKT RELATED DB: PDB REMARK 900 HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1HLS RELATED DB: PDB REMARK 900 NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16) REMARK 900 RELATED ID: 2CEU RELATED DB: PDB REMARK 900 DESPENTAPEPTIDE INSULIN IN ACETIC ACID (PH 2) REMARK 900 RELATED ID: 1T1Q RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ABA, REMARK 900 PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1QJ0 RELATED DB: PDB REMARK 900 HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR REMARK 900 RELATED ID: 1MHJ RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: REMARK 900 DES-[PHE(B 25)]; REMARK 900 RELATED ID: 1FU2 RELATED DB: PDB REMARK 900 FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION REMARK 900 DATA REMARK 900 RELATED ID: 1SJT RELATED DB: PDB REMARK 900 MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10) REMARK 900 ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1QIY RELATED DB: PDB REMARK 900 HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED REMARK 900 WITH PHENOL REMARK 900 RELATED ID: 1IOG RELATED DB: PDB REMARK 900 INSULIN MUTANT A3 GLY,(B1, B10, B16, B27) GLU, DES-B30, NMR, 19 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 2VJZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS REMARK 900 RELATED ID: 1IOH RELATED DB: PDB REMARK 900 INSULIN MUTANT A8 HIS,(B1, B10, B16, B27) GLU, DES-B30, NMR, 26 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1TRZ RELATED DB: PDB REMARK 900 INSULIN (T3R3) COMPLEX WITH TWO ZINC IONS REMARK 900 RELATED ID: 1EVR RELATED DB: PDB REMARK 900 THE STRUCTURE OF THE RESORCINOL/INSULIN R6 HEXAMER REMARK 900 RELATED ID: 1EV3 RELATED DB: PDB REMARK 900 STRUCTURE OF THE RHOMBOHEDRAL FORM OF THE M-CRESOL/INSULIN R6 REMARK 900 HEXAMER REMARK 900 RELATED ID: 1RWE RELATED DB: PDB REMARK 900 ENHANCING THE ACTIVITY OF INSULIN AT RECEPTOR EDGE: REMARK 900 CRYSTALSTRUCTURE AND PHOTO- CROSS-LINKING OF A8 ANALOGUES REMARK 900 RELATED ID: 1OS4 RELATED DB: PDB REMARK 900 DEHYDRATED T6 HUMAN INSULIN AT 295 K REMARK 900 RELATED ID: 1GUJ RELATED DB: PDB REMARK 900 INSULIN AT PH 2: STRUCTURAL ANALYSIS OF THE CONDITIONS PROMOTING REMARK 900 INSULIN FIBRE FORMATION. REMARK 900 RELATED ID: 1AI0 RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1SF1 RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN UNDER AMYLOIDOGENICCONDITION, 15 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1JCO RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE MONOMERIC [THR(B27 )->PRO,PRO(B28)->THR] REMARK 900 INSULIN MUTANT (PT INSULIN) REMARK 900 RELATED ID: 1JCA RELATED DB: PDB REMARK 900 NON-STANDARD DESIGN OF UNSTABLE INSULIN ANALOGUES WITHENHANCED REMARK 900 ACTIVITY REMARK 900 RELATED ID: 1ZEG RELATED DB: PDB REMARK 900 STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL REMARK 900 RELATED ID: 1OS3 RELATED DB: PDB REMARK 900 DEHYDRATED T6 HUMAN INSULIN AT 100 K REMARK 900 RELATED ID: 1XGL RELATED DB: PDB REMARK 900 HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1T0C RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN PROINSULIN C- PEPTIDE REMARK 900 RELATED ID: 1QIZ RELATED DB: PDB REMARK 900 HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED REMARK 900 WITH RESORCINOL REMARK 900 RELATED ID: 1G7B RELATED DB: PDB REMARK 900 1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K REMARK 900 RELATED ID: 2WBY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH REMARK 900 INSULIN REMARK 900 RELATED ID: 2AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1EV6 RELATED DB: PDB REMARK 900 STRUCTURE OF THE MONOCLINIC FORM OF THE M -CRESOL/INSULIN R6 HEXAMER REMARK 900 RELATED ID: 1Q4V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRALANALOGUE: REMARK 900 IMPLICATIONS FOR THE MECHANISM OF RECEPTOR REMARK 900 RELATED ID: 2HH4 RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-D-SER, HIS-B10-ASP REMARK 900 PRO-B28-LYS, LYS -B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 2H67 RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B5-ALA, HIS-B10-ASP PRO- REMARK 900 B28-LYS, LYS- B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 4AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' GREEN' SUBSTATE, REMARK 900 AVERAGE STRUCTURE REMARK 900 RELATED ID: 1J73 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN UNSTABLE INSULIN ANALOG WITH NATIVEACTIVITY. REMARK 900 RELATED ID: 1K3M RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALA, HIS-B10-ASP, PRO- REMARK 900 B28-LYS, LYS- B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1MHI RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: REMARK 900 S(B 9)D; REMARK 900 RELATED ID: 2WC0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH REMARK 900 IODINATED INSULIN REMARK 900 RELATED ID: 1KMF RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALLO-ILE, HIS-B10-ASP, REMARK 900 PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 2HIU RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1XW7 RELATED DB: PDB REMARK 900 DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN : CRYSTALSTRUCTURE REMARK 900 AND PHOTO-CROSS-LINKING STUDIES OF A-CHAINVARIANT INSULIN WAKAYAMA REMARK 900 RELATED ID: 5AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' RED' SUBSTATE, AVERAGE REMARK 900 STRUCTURE REMARK 900 RELATED ID: 1G7A RELATED DB: PDB REMARK 900 1.2 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K REMARK 900 RELATED ID: 1ZNJ RELATED DB: PDB REMARK 900 INSULIN, MONOCLINIC CRYSTAL FORM REMARK 900 RELATED ID: 1ZEH RELATED DB: PDB REMARK 900 STRUCTURE OF INSULIN REMARK 900 RELATED ID: 1HIS RELATED DB: PDB REMARK 900 INSULIN (HUMAN, DES-PENTAPEPTIDE (B 26 - B 30)) (NMR, REMARK 900 REPRESENTATIVE PLUS 14 STRUCTURES) REMARK 900 RELATED ID: 1B9E RELATED DB: PDB REMARK 900 HUMAN INSULIN MUTANT SERB9GLU REMARK 900 RELATED ID: 3AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1W8P RELATED DB: PDB REMARK 900 STRUCTURAL PROPERTIES OF THE B25TYR-NME- B26PHE INSULIN MUTANT. REMARK 900 RELATED ID: 1HIQ RELATED DB: PDB REMARK 900 INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY SER (F24S) (NMR, REMARK 900 REPRESENTATIVE PLUS 9 STRUCTURES) REMARK 900 RELATED ID: 1LPH RELATED DB: PDB REMARK 900 LYS(B28)PRO(B29)-HUMAN INSULIN REMARK 900 RELATED ID: 1EFE RELATED DB: PDB REMARK 900 AN ACTIVE MINI-PROINSULIN, M2PI REMARK 900 RELATED ID: 1A7F RELATED DB: PDB REMARK 900 INSULIN MUTANT B16 GLU, B24 GLY, DES-B30 , NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1T1P RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-THR, REMARK 900 PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1BEN RELATED DB: PDB REMARK 900 INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE REMARK 900 RELATED ID: 1LKQ RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-GLY, VAL-A3-GLY, HIS- REMARK 900 B10-ASP, PRO- B28-LYS, LYS-B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 2WS7 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI REMARK 900 RELATED ID: 2WS0 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 7.5 REMARK 900 RELATED ID: 2WS4 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI IN MONOMER FORM REMARK 900 RELATED ID: 2WS1 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN REMARK 900 MONOMER FORM REMARK 900 RELATED ID: 2WRX RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 3.0 REMARK 900 RELATED ID: 2WRW RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN D-PROB26-DTI- REMARK 900 NH2 REMARK 900 RELATED ID: 2WRU RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEALAB26- REMARK 900 DTI-NH2 REMARK 900 RELATED ID: 2WRV RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEHISB26- REMARK 900 DTI-NH2 REMARK 999 REMARK 999 SEQUENCE REMARK 999 N ATOM OF 26Y PEPTIDE IS METHYLATED DBREF 2WS6 A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2WS6 B 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 2WS6 C 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2WS6 D 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 2WS6 E 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2WS6 F 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 2WS6 G 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2WS6 H 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 2WS6 I 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2WS6 J 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 2WS6 K 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2WS6 L 1 30 UNP P01308 INS_HUMAN 25 54 SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 B 30 THR PRO LYS THR SEQRES 1 C 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 C 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 D 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 D 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 D 30 THR PRO LYS THR SEQRES 1 E 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 E 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 F 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 F 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE YNM SEQRES 3 F 30 THR PRO LYS THR SEQRES 1 G 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 G 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 H 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 H 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE YNM SEQRES 3 H 30 THR PRO LYS THR SEQRES 1 I 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 I 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 J 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 J 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE YNM SEQRES 3 J 30 THR PRO LYS THR SEQRES 1 K 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 K 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 L 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 L 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE YNM SEQRES 3 L 30 THR PRO LYS THR HET YNM F 26 13 HET YNM H 26 13 HET YNM J 26 13 HET YNM L 26 13 HET IPH A1022 7 HET IPH C1022 7 HET IPH E1022 7 HET IPH G1022 7 HET IPH I1022 7 HET CL J1029 1 HET ZN J1030 1 HET IPH K1022 7 HET CL L1028 1 HET ZN L1029 1 HET GOL L1030 6 HETNAM YNM N-METHYL-L-TYROSINE HETNAM IPH PHENOL HETNAM CL CHLORIDE ION HETNAM ZN ZINC ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 6 YNM 4(C10 H13 N O3) FORMUL 13 IPH 6(C6 H6 O) FORMUL 18 CL 2(CL 1-) FORMUL 19 ZN 2(ZN 2+) FORMUL 23 GOL C3 H8 O3 FORMUL 24 HOH *244(H2 O) HELIX 1 1 GLY A 1 CYS A 7 1 7 HELIX 2 2 SER A 12 GLU A 17 1 6 HELIX 3 3 PHE B 1 GLY B 20 1 20 HELIX 4 4 GLU B 21 GLY B 23 5 3 HELIX 5 5 GLY C 1 SER C 9 1 9 HELIX 6 6 SER C 12 ASN C 18 1 7 HELIX 7 7 PHE D 1 GLY D 20 1 20 HELIX 8 8 GLU D 21 GLY D 23 5 3 HELIX 9 9 GLY E 1 SER E 9 1 9 HELIX 10 10 SER E 12 ASN E 18 1 7 HELIX 11 11 VAL F 2 GLY F 20 1 19 HELIX 12 12 GLU F 21 GLY F 23 5 3 HELIX 13 13 GLY G 1 THR G 8 1 8 HELIX 14 14 SER G 12 ASN G 18 1 7 HELIX 15 15 PHE H 1 GLY H 20 1 20 HELIX 16 16 GLU H 21 GLY H 23 5 3 HELIX 17 17 GLY I 1 CYS I 7 1 7 HELIX 18 18 SER I 12 ASN I 18 1 7 HELIX 19 19 PHE J 1 GLY J 20 1 20 HELIX 20 20 GLU J 21 GLY J 23 5 3 HELIX 21 21 GLY K 1 CYS K 7 1 7 HELIX 22 22 SER K 12 GLU K 17 1 6 HELIX 23 23 ASN K 18 CYS K 20 5 3 HELIX 24 24 PHE L 1 GLY L 20 1 20 HELIX 25 25 GLU L 21 GLY L 23 5 3 SHEET 1 BA 2 PHE B 24 PHE B 25 0 SHEET 2 BA 2 PHE D 25 TYR D 26 -1 O TYR D 26 N PHE B 24 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.02 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.03 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.07 SSBOND 4 CYS C 6 CYS C 11 1555 1555 2.01 SSBOND 5 CYS C 7 CYS D 7 1555 1555 2.09 SSBOND 6 CYS C 20 CYS D 19 1555 1555 2.00 SSBOND 7 CYS E 6 CYS E 11 1555 1555 2.04 SSBOND 8 CYS E 7 CYS F 7 1555 1555 2.01 SSBOND 9 CYS E 20 CYS F 19 1555 1555 2.01 SSBOND 10 CYS G 6 CYS G 11 1555 1555 2.02 SSBOND 11 CYS G 7 CYS H 7 1555 1555 2.03 SSBOND 12 CYS G 20 CYS H 19 1555 1555 2.02 SSBOND 13 CYS I 6 CYS I 11 1555 1555 2.02 SSBOND 14 CYS I 7 CYS J 7 1555 1555 2.06 SSBOND 15 CYS I 20 CYS J 19 1555 1555 2.04 SSBOND 16 CYS K 6 CYS K 11 1555 1555 2.02 SSBOND 17 CYS K 7 CYS L 7 1555 1555 2.06 SSBOND 18 CYS K 20 CYS L 19 1555 1555 2.04 LINK C PHE F 25 N YNM F 26 1555 1555 1.32 LINK C YNM F 26 N THR F 27 1555 1555 1.34 LINK C PHE H 25 N YNM H 26 1555 1555 1.31 LINK C YNM H 26 N THR H 27 1555 1555 1.32 LINK C PHE J 25 N YNM J 26 1555 1555 1.34 LINK C YNM J 26 N THR J 27 1555 1555 1.33 LINK C PHE L 25 N YNM L 26 1555 1555 1.33 LINK C YNM L 26 N THR L 27 1555 1555 1.32 LINK NE2 HIS B 10 ZN ZN J1030 1555 1555 2.09 LINK NE2 HIS D 10 ZN ZN L1029 1555 1555 1.99 LINK NE2 HIS F 10 ZN ZN J1030 1555 1555 2.11 LINK NE2 HIS H 10 ZN ZN L1029 1555 1555 2.10 LINK NE2 HIS J 10 ZN ZN J1030 1555 1555 2.06 LINK CL CL J1029 ZN ZN J1030 1555 1555 2.20 LINK NE2 HIS L 10 ZN ZN L1029 1555 1555 2.10 LINK CL CL L1028 ZN ZN L1029 1555 1555 2.21 SITE 1 AC1 6 CYS A 6 SER A 9 ILE A 10 CYS A 11 SITE 2 AC1 6 LEU B 11 HIS F 5 SITE 1 AC2 4 CYS C 6 ILE C 10 CYS C 11 LEU D 11 SITE 1 AC3 3 CYS E 6 ILE E 10 CYS E 11 SITE 1 AC4 6 VAL D 2 CYS G 6 SER G 9 ILE G 10 SITE 2 AC4 6 CYS G 11 LEU H 11 SITE 1 AC5 5 HIS B 5 CYS I 6 ILE I 10 CYS I 11 SITE 2 AC5 5 LEU J 11 SITE 1 AC6 4 HIS B 10 HIS F 10 HIS J 10 ZN J1030 SITE 1 AC7 4 HIS B 10 HIS F 10 HIS J 10 CL J1029 SITE 1 AC8 5 HIS H 5 CYS K 6 ILE K 10 CYS K 11 SITE 2 AC8 5 LEU L 11 SITE 1 AC9 4 HIS D 10 HIS H 10 HIS L 10 ZN L1029 SITE 1 BC1 4 HIS D 10 HIS H 10 HIS L 10 CL L1028 SITE 1 BC2 6 GLY K 1 ILE K 2 PHE L 25 YNM L 26 SITE 2 BC2 6 THR L 27 HOH L2026 CRYST1 58.962 61.927 47.297 90.00 111.90 90.00 P 1 21 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016960 0.000000 0.006818 0.00000 SCALE2 0.000000 0.016148 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022787 0.00000